Browsing by Author "Garcia-Carbonero, Rocio"
Now showing items 1-6 of 6
-
Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study
Yoshino, T.; Portnoy, D. C.; Obermannova, Radka; Bodoky, György; Prausová, J.; Tabernero Caturla, Josep; Garcia-Carbonero, Rocio (Oxford University Press, 2019-01-01) -
Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer
Borrero-Palacios, Áurea; Cebrián, A; Gómez Del Pulgar, MT; García, P; Elez Fernandez, Mª Elena; Garcia-Carbonero, Rocio; Aranda Aguilar, Enrique (Nature Research, 2019-02-22) -
Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin
Hernando Cubero, Jorge; Teule, Alex; Lopez, C.; Garcia-Carbonero, Rocio; Benavent, Marta; Landolfi, Stefania; Capdevila Castillon, Jaume; Nuciforo, Paolo (Nature Portfolio, 2023-05-23) -
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors
Bazan-Peregrino, Miriam; Gil Martín, Marta; Álvarez, Rafael; Macarulla Mercadé, Teresa; Riesco-Martinez, Maria; Verdaguer Mata, Helena; Garcia-Carbonero, Rocio (BMJ, 2022-03) -
SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)
Gómez España, Maria Auxiliadora; Fernández Montes, Ana; Macarulla Mercadé, Teresa; Maurel, Joan; Muñoz Martin, Andrés; Garcia-Carbonero, Rocio (Springer, 2021-05) -
VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02)
Feliu, Jaime; Guasch, Inmaculada; Alonso-Orduna, Vicente; López Gil, Carlos; Capdevila Castillon, Jaume; Garcia-Carbonero, Rocio (Wiley, 2020-02)